AstraZeneca PLC

AZN · Nasdaq Stockholm · Healthcare

1,574.00SEK −1.6%last day

Price as of 2 October 2026

The price over the past year, with dividends: +12.7%

Performance

1 month

+0.2%

1 year

+12.7%

3 years, per year

+3.4%

5 years, per year

+11.8%

Largest fall, 3 years

−29.9%

Below the peak now

−16.7%

Volatility, 1 year

27.3%

Return with dividends reinvested.

Key figures

P/E

23.4

P/B

4.8

Dividend yield

1.9%

Return on equity

+20.6%

Net margin

+17.0%

Market value

244.3 bn USD

Quality, value and trend

Where AstraZeneca stands against every Nordic stock today. 100 is best.

Quality78

Profitability and a sound balance sheet over time. Better than 78% of Nordic stocks.

Value26

The price measured against earnings, assets and cash flow. Better than 26% of Nordic stocks.

Trend31

The price development over the past year. Better than 31% of Nordic stocks.

Combined38

Quality, value and trend together. Better than 38% of Nordic stocks.

About AstraZeneca

AstraZeneca PLC is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 96,000 employees.

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhal…

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis